[1] |
TABATA M,KADOMATSU T,FUKUHARA S,et al.Angiopoietin-like protein 2 promotes chronic adipose tissue inflammation and obesity-related systemic insulin resistance[J]. Cell Metab,2009,10(3):178-188.
|
[2] |
FAGIANI E,CHRISTOFORI G.Angiopoietins in angiogenesis[J]. Cancer Lett,2013,328(1):18-26.
|
[3] |
MATSUO Y,AZUMA Y T,KUWAMURA M,et al.Interleukin 19 reduces inflammation in chemically induced experimental colitis[J]. Int Immunopharmacol,2015,29(2):468-475.
|
[4] |
BARRETT J C,CLAYTON D G,CONCANNON P,et al.Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes[J]. Nat Genet,2009,41(6):703-707.
|
[5] |
DABHI B,MISTRY K N,PATEL H,et al.Vascular endothelial growth factor insertion/deletion gene polymorphism in West Indian patients of type 2 diabetes and diabetic nephropathy[J]. Indian J Biochem Biophys,2015,52(2):209-212.
|
[6] |
BONOMINI M,PANDOLFI A.Chemerin in renal dysfunction and cardiovascular disease[J]. Vascul Pharmacol,2016,77:28-34.
|
[7] |
MOON J Y,JEONG K H,LEE T W,et al.Aberrant recruitment and activation of T cells in diabetic nephropathy[J]. Am J Nephrol,2012,35(2):164-174.
|
[8] |
FIELDING C A.Interleukin-19:a new target to aim for?[J]. Rheumatology(Oxford),2012,51(3):399-400.
|
[9] |
SABAT R,WALLACE E,ENDESFELDER S,et al.IL-19 and IL-20:two novel cytokines with importance in inflammatory diseases[J]. Expert Opin Ther Targets,2007,11(5):601-612.
|
[10] |
CUNEO A A,HERRICK D,AUTIERI M V.IL-19 reduces VSMC activation by regulation of mRNA regulatory factor HuR and reduction of mRNA stability[J]. J Mol Cell Cardiol,2010,49(4):647-654.
|
[11] |
SAVASAN Z A,CHAIWORAPONGSA T,ROMERO R,et al.Interleukin-19 in fetal systemic inflammation[J]. J Matern Fetal Neonatal Med,2012,25(7):995-1005.
|
[12] |
GABUNIA K,AUTIERI M V.Interleukin 19 can enhance angiogenesis by macrophage polarization[J]. Macrophage(Houst),2015,2(1):e562.
|
[13] |
JENNINGS P,CREAN D,ASCHAUER L,et al.Interleukin-19 as a translational indicator of renal injury[J]. Arch Toxicol,2015,89(1):101-106.
|
[14] |
JAIN S,GABUNIA K,KELEMEN S E,et al.The anti-inflammatory cytokine interleukin 19 is expressed by and angiogenic for human endothelial cells[J]. Arterioscler Thromb Vasc Biol,2011,31(1):167-175.
|
[15] |
American Diabetes Association.Standards of medical care in diabetes-2010[J]. Diabetes Care,2010,33(Suppl 1):S11-S61.
|
[16] |
李卿,居漪,金中淦,等. 糖化血红蛋白IFCC参考方法及实验室网络比对[J]. 检验医学,2016,31(7):607-609.
|